These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4363375)

  • 1. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: the action of L-dopa.
    Bergonzi P; Chiurulla C; Cianchetti C; Tempesta E
    Confin Neurol; 1974; 36(1):5-22. PubMed ID: 4363375
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sleep in patients with Parkinson's disease and its influence by L-DOPA (author's transl)].
    Schneider E; Maxion H; Ziegler B; Jacobi P
    J Neurol; 1974 Jun; 207(2):95-108. PubMed ID: 4135843
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of L-DOPA on night sleep in parkinsonian patients].
    Kendel K; Beck U; Wita C; Hohneck E; Zimmermann H
    Arch Psychiatr Nervenkr (1970); 1972; 216(1):82-100. PubMed ID: 4341587
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of L-DOPA on sleep spindles in patients with parkinsonism].
    Bricolo A; Sciarretta G; Mazza C; Turella G
    Riv Sper Freniatr Med Leg Alien Ment; 1970 Apr; 94(2):416-24. PubMed ID: 4320855
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism.
    Puca FM; Bricolo A; Turella G
    Electroencephalogr Clin Neurophysiol; 1973 Sep; 35(3):327-30. PubMed ID: 4126184
    [No Abstract]   [Full Text] [Related]  

  • 6. The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.
    Altier H; Moldes M; Monti JM
    Br J Pharmacol; 1975 May; 54(1):101-6. PubMed ID: 166716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polygraphic study of nocturnal sleep in Parkinsonian syndromes. Effects of treatment levo-dopa].
    Muratorio A; Murri L; Cerone G
    Riv Neurobiol; 1970; 16(4):361-76. PubMed ID: 4350093
    [No Abstract]   [Full Text] [Related]  

  • 8. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration.
    Kales A; Ansel RD; Markham CH; Scharf MB; Tan TL
    Clin Pharmacol Ther; 1971; 12(2):397-406. PubMed ID: 4325251
    [No Abstract]   [Full Text] [Related]  

  • 9. [Organization of nocturnal sleep in parkinsonian patients: modifications of the phases and cycles in the course of pharmacological treatment].
    Bergonzi P; Chiurulla C; Tempesta E
    Riv Neurol; 1971; 41(5):326-34. PubMed ID: 4334666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in nocturnal sleep in parkinsonism patients treated with L-dopa].
    Bricolo A; Turella G; Mazza CA; Buffatti P; Grosslercher JC
    Sist Nerv; 1970; 22(2):181-90. PubMed ID: 4323416
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of L-DOPA on natural night sleep and on rebound of REM sleep.
    Nakazawa Y; Tachibana H; Kotorii M; Ogata M
    Folia Psychiatr Neurol Jpn; 1973; 27(3):223-30. PubMed ID: 4356561
    [No Abstract]   [Full Text] [Related]  

  • 12. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Biol Psychiatry; 1970 Oct; 2(4):341-66. PubMed ID: 4920729
    [No Abstract]   [Full Text] [Related]  

  • 13. REM inhibitory effect of L-DOPA infusion during human sleep.
    Gillin JC; Post RM; Wyatt RJ; Goodwin FK; Snyder F; Bunney WE
    Electroencephalogr Clin Neurophysiol; 1973 Aug; 35(2):181-6. PubMed ID: 4124610
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of loxapine on the sleep-wakefulness cycle of the rat.
    Schmidek WR; Timo-Iaria C; Schmidek M; Krakowiak M; Delmutti EE; Alves MR
    Pharmacol Biochem Behav; 1974; 2(6):747-51. PubMed ID: 4377026
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of L-dopa on the sleep of man.
    Wyatt RJ; Chase TN; Scott J; Snyder F; Engleman K
    Nature; 1970 Dec; 228(5275):999-1001. PubMed ID: 4320512
    [No Abstract]   [Full Text] [Related]  

  • 16. L-dopa and REM sleep in normal and mentally retarded subjects.
    Castaldo V; Krynicki VE; Crade M
    Biol Psychiatry; 1973 Jun; 6(3):295-9. PubMed ID: 4354507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
    Sato G; Ito H; Handa Y; Takahashi I; Iijima K
    No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influences of hypnotics (especially nitrazepam, -hydroxybutyric acid) on sleep-wakefulness mechanisms in cats].
    Takeshima T
    Seishin Shinkeigaku Zasshi; 1971 Jun; 73(6):495-532. PubMed ID: 4328480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Normal and pathological sleep. Clinical and experimental cases in relation to catecholamines during the use of L-Dopa].
    Delmar A; Kuziora IF; Pozzo R; D'Alberto N; Di Marco M
    Prensa Med Argent; 1970 Oct; 57(35):1649-53. PubMed ID: 4396056
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of L-dopa in autism.
    Ritvo ER; Yuwiler A; Geller E; Kales A; Rashkis S; Schicor A; Plotkin S; Axelrod R; Howard C
    J Autism Child Schizophr; 1971; 1(2):190-205. PubMed ID: 4335857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.